Form 4: DaVita Executive Sells Shares via 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Kathleen Alyce Waters, Chief Legal & Public Affairs Officer at DaVita Inc., sold 15,405 shares of common stock.
Summary
- Kathleen Alyce Waters, Chief Legal & Public Affairs Officer of DaVita Inc., executed the sale of 15,405 shares of common stock on June 15, 2026.
- The shares were sold in two tranches: 8,950 shares at a weighted average price of $207.844 and 6,455 shares at a weighted average price of $209.167.
- Following these transactions, the reporting person retains beneficial ownership of 109,194 shares of DaVita common stock.
- The sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 16, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed through a pre-established 10b5-1 plan, which is a standard practice for executive financial planning.
Positives
- The transaction was pre-planned under a Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without concerns regarding insider trading.
Negatives
- The sale represents a reduction in the executive's direct equity stake in the company.
Risks
- None identified in this filing.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that executive stock sales conducted under 10b5-1 plans are routine corporate governance events and generally do not signal a change in company fundamentals or management sentiment.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate executives to manage personal liquidity while maintaining compliance with SEC regulations.
Stakeholder Impact
- Minimal impact on shareholders as the sale was pre-planned and represents a small portion of the executive's total holdings.
Key Dates
| Date | Description |
|---|---|
| 03/16/2026 | Date the Rule 10b5-1 trading plan was adopted. |
| 06/15/2026 | Date of the reported stock sale transactions. |
| 06/17/2026 | Date the Form 4 was signed and filed. |
Keywords
DaVita, DVA, Insider Trading, Form 4, Equity Sale, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.